ENDRA Life Sciences Inc. — Director's Dealing 2019

Mar 27, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ENDRA Life Sciences Inc. (NDRA)
CIK: 0001681682
Period of Report: 2019-03-25

Reporting Person: Tokman Alexander Y (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-03-25	Stock Options	$3.09	A	50000	Acquired	2019-03-25	Common Stock (50000)	Direct

Footnotes

F1: Represents a stock option award granted on March 25, 2019 pursuant to the Issuer's Non-Employee Director Compensation Policy.

F2: This stock option grant becomes exercisable in three equal annual installments beginning March 25, 2020.